Latest Drug Enforcement Administration Stories
WASHINGTON, Aug. 24, 2011 /PRNewswire-USNewswire/ -- The Drug Enforcement Administration (DEA) delivered yet another blow to privately funded medical marijuana research last week, despite the Obama administration's promises to prioritize science over politics when it came to medical marijuana. On Monday, August 15, 2011, the DEA issued its final order rejecting DEA Administrative Law Judge Mary Ellen Bittner's recommendation that it would be in the public interest to grant University of...
NASHVILLE, Tenn., Aug. 15, 2011 /PRNewswire/ -- Emdeon Inc. (NYSE: EM), a leading provider of healthcare revenue and payment cycle management and clinical information exchange solutions, today announced its support for the U.S. Drug Enforcement Administration's (DEA's) quicker-to-market option for electronic prescribing of controlled substances (EPCS). On June 1, 2010, prescribers became legally allowed to electronically transmit controlled substance prescriptions to the pharmacy of a...
ROCKVILLE, Md., July 27, 2011 /PRNewswire/ -- Today, DrFirst, Inc. announced an innovative product that fulfills the company's commitment to deliver a simple, secure, and affordable way to send controlled substance prescriptions electronically with the launch of EPCS Gold(TM) version 2.0 (Electronic Prescribing of Controlled Substances). EPCS Gold(TM) is fully certified to meet the prescription processing requirements set by Surescripts, the Drug Enforcement Administration (DEA)...
Lawsuits alleging illegal prescribing of dangerous narcotics and opiates causing the deaths of two young men were filed in the Orange County Superior Court on behalf of the families against Dr. Lisa Tseng. "Dr. Tseng is under investigation by the California Medical Board and the DEA and her license to prescribe narcotics has already been revoked," said Irvine attorney Larry Eisenberg who is representing the families. Irvine, CA (PRWEB) July 08, 2011 Lawsuits alleging illegal...
PRINCETON, N.J., June 28, 2011 /PRNewswire/ -- GE Healthcare today announced the availability of DaTscan(TM) (Ioflupane I 123 Injection), in more than 80 hospitals across the US. DaTscan is the first FDA-approved radiopharmaceutical adjunct imaging agent to help physicians evaluate patients with suspected parkinsonian syndromes (PS), such as Parkinson's disease (PD). It gives physicians diagnostic capability that may lead to timely, appropriate treatments for suspected PS patients. "This is...
Study identifies over 1,000 websites still selling controlled substance medicines without a valid prescription PORTLAND, Ore., June 8, 2011 /PRNewswire-USNewswire/ -- A new report criticizes the US Drug Enforcement Administration for not doing enough about rogue online pharmacies selling addictive medications without a valid prescription requirement. The report, issued by Internet pharmacy monitoring service LegitScript.com, analyzes the DEA's implementation of the Ryan Haight Online...
COSTA MESA, Calif., June 1, 2011 /PRNewswire/ -- Experian® today announced that they and Symantec have provided DrFirst, the nation's leading electronic prescribing company (e-prescribing), with an authentication solution for its newest product, EPCS Gold(TM). The Experian and Symantec products will allow DrFirst to securely and accurately deliver secure online identity credentials to physicians who are eligible to issue e-prescriptions for controlled substances to their patients through...
CORAL SPRINGS, Fla., June 1, 2011 /PRNewswire-USNewswire/ -- Thirty-two States have rules in place that allow electronic transmission of controlled substances, according to the ePrescribing Law Survey, the most comprehensive, up-to-date compendium of State and Federal pharmacy statutes and regulations just updated by Point-of-Care Partners (POCP). Nearly a year ago, the Drug Enforcement Administration (DEA) issued its interim final rule. The ePrescribing Law Survey, updated through the...
Second Nationwide Prescription Drug Takeback Event Yields 188 Tons of Medicine for Safe Disposal Washington, DC (PRWEB) May 06, 2011 Americans participating in the United States Drug Enforcement Administration's (DEA's) second National Prescription Drug Take-Back event Saturday turned in more than 376,593 pounds (188 tons) of unwanted or expired medications for safe and proper disposal at the 5,361 take-back sites that were available in all 50 states. This is 55 percent more than the...
PORTLAND, Ore., April 26, 2011 /PRNewswire/ -- In a nationwide effort to clear homes of potentially dangerous, expired, unused, and unwanted prescription drugs, RegenceRx is supporting the Drug Enforcement Administration's (DEA) National Prescription Drug Take-Back Day taking place on Saturday, April 30. "Unused or expired medications pose safety risks to our members and their families that they may not be aware of. RegenceRx is participating in Drug Take-Back Day to help increase...
